Findings

What do systematic reviews say?

5 questions · 5 findings · 4 reviews · Epilepsy

Sort:Best matchNewest Highest certainty Download CSV

No studies found 2 · 40%GRADE not reported 0 · 0%Very low 2 · 40%Low 0 · 0%Moderate 1 · 20%High 0 · 0%

Add‐on felbamate vs placebo

Quality of life · people with drug‐resistant focal epilepsy

1 finding from 1 review

Felbamate add‐on therapy for drug‐resistant focal epilepsy 2022 · Cochrane Headline outcomes only
no estimate extracted
1 study · 64 participants
Very low

Stiripentol vs add‐on placebo

Quality of life · people with drug‐resistant focal epilepsy

The review found no eligible studies for this question.

1 finding from 1 review

Stiripentol add‐on therapy for drug‐resistant focal epilepsy 2022 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Sulthiame add‐on vs placebo

Quality of life · patients between 3 to 15 months of age with West syndrome

The review found no eligible studies for this question.

1 finding from 1 review

Sulthiame add‐on therapy for epilepsy 2019 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Selective serotonin reuptake inhibitors vs cognitive behavioural therapy

Post‐treatment quality of life (QOLIE‐31 score, which has a range of 0‐200, with higher score indicates better quality of life) ( · people with epilepsy and depression

1 finding from 1 review

Antidepressants for people with epilepsy and depression 2021 · Cochrane Headline outcomes only
no estimate extracted
15 participants
Very low

Sertraline vs cognitive behavioural therapy

Quality of life (QOLIE‐89) (1‐ to 3‐month periods) · people with epilepsy and depression

1 finding from 1 review

Antidepressants for people with epilepsy and depression 2021 · Cochrane Headline outcomes only
no estimate extracted
1 study · 118 participants
Moderate